{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:02Z","timestamp":1791928922732,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.trre.2023.100815","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T20:20:45Z","timestamp":1701894045000},"page":"100815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The association between tacrolimus exposure and tremor, headache and insomnia in adult kidney transplant recipients: A systematic review"],"prefix":"10.1016","volume":"38","author":[{"given":"Catherine P.","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia R.","family":"Cossart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Isbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott B.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Staatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2023.100815_bb0005","series-title":"Australia and New Zealand dialysis and transplant registry. Adelaide, Australia","article-title":"45th report, chapter 7: kidney transplantation","author":"ANZDATA Registry","year":"2022"},{"key":"10.1016\/j.trre.2023.100815_bb0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpsychores.2008.07.017","article-title":"Symptom experience after solid organ transplantation","volume":"66","author":"Kugler","year":"2009","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.trre.2023.100815_bb0015","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1007\/s11096-018-0652-6","article-title":"Unintentional and intentional non-adherence to immunosuppressive medications in renal transplant recipients","volume":"40","author":"Griva","year":"2018","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.trre.2023.100815_bb0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/nep.13214","article-title":"Investigating barriers to immunosuppressant medication adherence in renal transplant patients","volume":"24","author":"Cossart","year":"2019","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.trre.2023.100815_bb0025","first-page":"170","article-title":"Neurotoxicity of immunosuppressive therapies in organ transplantation","volume":"8","author":"Anghel","year":"2013","journal-title":"Maedica (Buchar)"},{"key":"10.1016\/j.trre.2023.100815_bb0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/aor.13551","article-title":"Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity","volume":"44","author":"Bentata","year":"2020","journal-title":"Artif Organs"},{"key":"10.1016\/j.trre.2023.100815_bb0035","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1097\/TP.0000000000001453","article-title":"Incidence of posttransplantation diabetes mellitus in de novo kidney transplant recipients receiving prolonged-release tacrolimus-based immunosuppression with 2 different corticosteroid minimization strategies: advance, a randomized controlled trial","volume":"101","author":"Mourad","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2023.100815_bb0040","first-page":"2","article-title":"The burden of gastrointestinal complaints in kidney transplant recipients using tacrolimus with and without mycophenolate mofetil: a randomized controlled study","author":"Fatly","year":"2022","journal-title":"Front Nephrol (Online)"},{"key":"10.1016\/j.trre.2023.100815_bb0045","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1053\/jlts.2001.27475","article-title":"Neurotoxicity of immunosuppressive drugs","volume":"7","author":"Wijdicks","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2023.100815_bb0050","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4103\/ijot.ijot_65_20","article-title":"A prospective study of correlation of blood levels of tacrolimus to graft function and adverse effect of tacrolimus in postrenal transplant patients","volume":"14","author":"Asuri","year":"2020","journal-title":"Indian J Transplant"},{"key":"10.1016\/j.trre.2023.100815_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.10951","article-title":"Tremor, daily functioning, and health-related quality of life in solid organ transplant recipients","volume":"36","author":"Riemersma","year":"2023","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2023.100815_bb0060","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/ctr.12581","article-title":"Switching study of kidney transplant patients with tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study","volume":"29","author":"Langone","year":"2015","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2023.100815_bb0065","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s00415-018-8904-x","article-title":"Tremor induced by calcineurin inhibitor immunosuppression: a single-centre observational study in kidney transplanted patients","volume":"265","author":"Erro","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.trre.2023.100815_bb0070","first-page":"121S","article-title":"Sympathetic neural mechanisms of cyclosporine-induced hypertension","volume":"9","author":"Sander","year":"1996","journal-title":"AJH"},{"key":"10.1016\/j.trre.2023.100815_bb0075","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2214\/ajr.166.3.8623651","article-title":"Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity","volume":"166","author":"Appignani","year":"1996","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.trre.2023.100815_bb0080","first-page":"3175","article-title":"Neurologic complications of FK 506","volume":"23","author":"Eidelman","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2023.100815_bb0085","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1681\/ASN.2018010009","article-title":"Everolimus with reduced calcineurin inhibitor exposure in renal transplantation","volume":"29","author":"Pascual","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2023.100815_bb0090","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/FPC.0b013e328364db84","article-title":"PharmGKB summary: cyclosporine and tacrolimus pathways","volume":"23","author":"Barbarino","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.trre.2023.100815_bb0095","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40262-019-00854-1","article-title":"Unbound plasma, total plasma, and whole-blood tacrolimus pharmacokinetics early after thoracic organ transplantation","volume":"59","author":"Sikma","year":"2020","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.trre.2023.100815_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123709","article-title":"Expeditious quantification of plasma tacrolimus with liquid chromatography tandem mass spectrometry in solid organ transplantation","volume":"1222","author":"Zijp","year":"2023","journal-title":"J Chromatogr B"},{"issue":"8","key":"10.1016\/j.trre.2023.100815_bb0105","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s40262-023-01259-x","article-title":"A joint pharmacokinetic model for the simultaneous description of plasma and whole blood tacrolimus concentrations in kidney and lung transplant recipients","volume":"62","author":"Koomen","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.trre.2023.100815_bb0110","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1365-2125.2003.02008.x","article-title":"Factors affecting variability in distribution of tacrolimus in liver transplant recipients: factors affecting distribution of tacrolimus","volume":"57","author":"Zahir","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.trre.2023.100815_bb0115","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/FTD.0000000000000780","article-title":"Measuring intracellular concentrations of calcineurin inhibitors: expert consensus from the international association of therapeutic drug monitoring and clinical toxicology expert panel","volume":"42","author":"Lemaitre","year":"2020","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trre.2023.100815_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2021.100610","article-title":"Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: a systematic review","volume":"35","author":"Braithwaite","year":"2021","journal-title":"Transplant Rev (Orlando)"},{"issue":"4","key":"10.1016\/j.trre.2023.100815_bb0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40268-023-00428-4","article-title":"Tremor induced by cyclosporine, tacrolimus, sirolimus, or everolimus: a review of the literature","volume":"23","author":"Wagle Shukla","year":"2023","journal-title":"Drugs R&D"},{"key":"10.1016\/j.trre.2023.100815_bb0130","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s12913-014-0579-0","article-title":"PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews","volume":"14","author":"Methley","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.trre.2023.100815_bb0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0004-9514(09)70043-1","article-title":"The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study","volume":"55","author":"de Morton","year":"2009","journal-title":"Aust J Physiother"},{"key":"10.1016\/j.trre.2023.100815_bb0140","series-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2021"},{"key":"10.1016\/j.trre.2023.100815_bb0145","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0006-3223(95)00395-9","article-title":"Prospective study of FK506 side effects: anxiety or akathisia?","volume":"40","author":"DiMartini","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.trre.2023.100815_bb0150","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14550","article-title":"Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of de novo kidney transplant recipients: the better study","volume":"36","author":"Fernandez Rivera","year":"2022","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2023.100815_bb0155","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001315","article-title":"Association of extrarenal adverse effects of posttransplant immunosuppression with sex and ABCB1 haplotypes","volume":"94","author":"Venuto","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.trre.2023.100815_bb0160","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/ajt.13935","article-title":"A steady-state head-to-head pharmacokinetic comparison of all FK-506 (tacrolimus) formulations (ASTCOFF): an open-label, prospective, randomized, two-arm, three-period crossover study","volume":"17","author":"Tremblay","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2023.100815_bb0165","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/phar.2300","article-title":"Tacrolimus concentration-to-dose ratios in kidney transplant recipients and relationship to clinical outcomes","volume":"39","author":"Bartlett","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.trre.2023.100815_bb0170","series-title":"Deep brain stimulation management","first-page":"213","article-title":"Fahn\u2013Tolosa\u2013Marin tremor rating scale","author":"Appendix","year":"2015"},{"key":"10.1016\/j.trre.2023.100815_bb0175","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.parkreldis.2005.05.009","article-title":"Quality of life in essential tremor questionnaire (QUEST): development and initial validation","volume":"11","author":"Tr\u00f6ster","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.trre.2023.100815_bb0180","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/00007890-199610150-00005","article-title":"An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States multicenter FK506 kidney transplant group","volume":"62","author":"Laskow","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2023.100815_bb0185","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/bcp.13811","article-title":"The impact of tacrolimus exposure on extrarenal adverse effects in adult renal transplant recipients","volume":"85","author":"Campagne","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.trre.2023.100815_bb0190","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.transproceed.2021.01.034","volume":"53","author":"Hugo","year":"2021","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2023.100815_bb0195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.15586\/jrenhep.2020.68","article-title":"Conversion from extended-dose-release tacrolimus to melt-dose tacrolimus in high metabolizer patients: is the new formulation of lpct the best option for high metabolizer kidney transplanted patients?","volume":"4","author":"Carta","year":"2020","journal-title":"J Renal Hepatic Disorders"},{"key":"10.1016\/j.trre.2023.100815_bb0200","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13767","article-title":"Effectiveness and safety of the conversion to MeltDose(\u00ae) extended-release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: a retrospective study","volume":"34","author":"S\u00e1nchez Fructuoso","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2023.100815_bb0205","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/ajt.12035","article-title":"Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial","volume":"13","author":"Bunnapradist","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2023.100815_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2021.10225","article-title":"Prolonged-release once-daily formulation of tacrolimus versus standard-of-care tacrolimus in de novo kidney transplant patients across Europe","volume":"35","author":"Budde","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2023.100815_bb0215","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40266-021-00842-w","article-title":"Clinical experience with extended-release tacrolimus in older adult kidney transplant recipients: a retrospective cohort study","volume":"38","author":"January","year":"2021","journal-title":"Drugs Aging"},{"key":"10.1016\/j.trre.2023.100815_bb0220","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1053\/j.ajkd.2015.10.024","article-title":"Novel once-daily extended-release tacrolimus versus twice-daily tacrolimus in de novo kidney transplant recipients: two-year results of phase 3, double-blind, randomized trial","volume":"67","author":"Rostaing","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.trre.2023.100815_bb0225","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/cts.13495","article-title":"Age associations with tacrolimus and mycophenolic acid pharmacokinetics in stable black and white kidney transplant recipients: implications for health inequities","volume":"16","author":"Tornatore","year":"2023","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.trre.2023.100815_bb0230","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/phar.2656","article-title":"Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients","volume":"42","author":"Tornatore","year":"2022","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.trre.2023.100815_bb0235","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2125.2010.03815.x","article-title":"Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients","volume":"71","author":"Barraclough","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.trre.2023.100815_bb0240","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/TP.0b013e3182962cc1","article-title":"Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients","volume":"96","author":"Gaber","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2023.100815_bb0245","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/cts.13206","article-title":"A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients","volume":"15","author":"Bunthof","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.trre.2023.100815_bb0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/157488611794480043","article-title":"Adverse effects of tacrolimus in renal transplant patients from living donors","volume":"6","author":"Bulatova","year":"2011","journal-title":"Curr Drug Saf"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X23000691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X23000691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T16:07:41Z","timestamp":1760630861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X23000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0955470X23000691"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2023.100815","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between tacrolimus exposure and tremor, headache and insomnia in adult kidney transplant recipients: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2023.100815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100815"}}